Journal of Hematology & Thromboembolic Diseases
Open Access

Omer Iqbal

Biography

Working in the areas of monitoring and reversal of NOACs and also pathogenesis of keratoconus, macular degeneration and Stevens Johnson Syndrome/Toxic Epidermal Necrolysis. Engaged in research on CRISPR/Cas9 genomic disruption of VEGF-A expression in human Retinal pigment Epithelial cells compared to chronic aspirin-induced genomic disruption of VEGF-A expression. Focusing now on Coronavirus-induced activation of coagulation and potential role of tPA and Enoxaparin or Apixaban.

Research Interest

 Clinical Laboratory Testing, Diagnosis of Blood Disorders, Monitoring of Anticoagulant Drugs, Diagnosis of Bleeding or Clotting Disorders.

Relevant Topics